Header image

AstraZeneca Mini Oral: Achieving 4-pillars in HFrEF – learns from a real world program

Friday, August 2, 2024
3:15 PM - 3:45 PM
Theatrette 7

Details

Join us for a CSANZ Mini-Oral with a Q&A, hosted by AstraZeneca, and engage with the lead clinicians from Advara HeartCare’s 2023 HFrEF Guideline Directed Initiative (GDI). This GDI identified ~2000 patients with HFrEF not on maximal-tolerated therapy and provided relevant nursing support to achieve this. This Q&A will provide practical insights into the program and enable you to ask questions to help optimise management for your HFrEF patients.

loading